Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials - Top-Institutions - MDSpire

Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials

  • By

  • Martin Walter

  • Christine zu Eulenburg

  • Ani Damyanova

  • Karin Schmid

  • Isabel Schwienbacher

  • Evangelos Papanastasiou

  • Katarina Maiboe

  • Lars Arvastson

  • Caren Strote

  • Daniel Gehrlach

  • Hans Eriksson

  • June 24, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Psychiatry

  • #2

    Medical University of Gdańsk
    Medical University of Gdańsk

    Gdańsk, Pomeranian Voivodeship

    Key Differentiators

    • Psychiatry

  • #3

    OM1 Mental Health Specialty Network
    OM1 Mental Health Specialty Network

    Boston, MA

    Key Differentiators

    • Psychiatry

Original Source(s)

Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials

  • by Martin Walter, Christine zu Eulenburg, Ani Damyanova, Karin Schmid, Isabel Schwienbacher, Evangelos Papanastasiou, Katarina Maiboe, Lars Arvastson, Caren Strote, Daniel Gehrlach, Hans Eriksson

  • June 24, 2026

Related Content

Co-expressed microRNAs associated with elevated psychometabolic risk phenotype in women during midlife

Symptom clusters mediate anxiety/depression effects on quality of life in neuromyelitis optica spectrum disorders: a cross-sectional mediation analysis

What is Collaborative Care? Reexamining the Principles of Collaborative Care Through Scaling to Complex Populations and Settings